Sarissa Capital Management as of Dec. 31, 2022
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 27.9 | $234M | 9.0M | 26.13 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 24.2 | $203M | 16M | 12.39 | |
| Biogen Idec (BIIB) | 21.2 | $178M | 643k | 276.92 | |
| Gilead Sciences (GILD) | 10.9 | $92M | 1.1M | 85.85 | |
| Innoviva (INVA) | 10.4 | $88M | 6.6M | 13.25 | |
| Mersana Therapeutics (MRSN) | 2.8 | $23M | 4.0M | 5.86 | |
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $11M | 980k | 11.48 | |
| Amarin Corp Spons Adr New (AMRN) | 0.7 | $5.8M | 4.8M | 1.21 | |
| Vor Biopharma (VOR) | 0.5 | $4.1M | 618k | 6.65 | |
| Pear Therapeutics Class A Com | 0.1 | $590k | 500k | 1.18 | |
| Regulus Therapeutics (RGLS) | 0.0 | $254k | 185k | 1.37 |
